Filing Details
- Accession Number:
- 0001517737-24-000071
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-06-12 10:54:34
- Reporting Period:
- 2024-06-10
- Accepted Time:
- 2024-06-12 10:54:34
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
883241 | Synopsys Inc | SNPS | Services-Prepackaged Software (7372) | 561546236 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1206990 | Jr F John Runkel | 675 Almanor Avenue Sunnyvale CA 94085 | Gc & Corporate Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-06-10 | 366 | $354.48 | 20,366 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-06-10 | 366 | $566.97 | 20,000 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2024-06-10 | 570 | $234.17 | 20,570 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-06-10 | 570 | $566.97 | 20,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2024-06-10 | 570 | $0.00 | 570 | $234.17 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2024-06-10 | 366 | $0.00 | 366 | $354.48 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
1,139 | 2021-12-10 | 2027-12-10 | No | 4 | M | Direct |
2,197 | 2022-12-09 | 2028-12-09 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted September 29, 2023.
- 1/4 of the grant becomes exercisable on the date shown with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date.